Significant De-leveraging Transaction Resulting in Overall Debt Reduction of Approximately $1.7 Billion THE WOODLANDS, Texas, Dec. 24, 2025 /PRNewswire/ --…
AUSTIN, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice.…
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
DUBAI, UAE, Dec. 23, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, in partnership with Mantle and…
NEW DELHI, Dec. 23, 2025 /PRNewswire/ -- Comviva, the global leader in digital transformation solutions, specializing in customer experience management,…
Self-drive rentals can bridge the 'EV Experience Gap', accelerating nationwide adoption.BENGALURU, India, Dec. 23, 2025 /PRNewswire/ -- Zoomcar Holdings, Inc.…
PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec.…
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on…
Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved…
The company is recognized for its innovation-driven strategy, strong execution, and global leadership in integrated smart building solutions.SAN ANTONIO, Dec.…